echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medical World News > Despite brexit uncertainty, the UK is still looking for deals and acquisitions

    Despite brexit uncertainty, the UK is still looking for deals and acquisitions

    • Last Update: 2021-02-26
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    uk's pharmaceutical industry is pushing ahead with mergers and acquisitions and can cope with any disruption caused by Brexit, according to a recent EY survey.EY's 19th Capital Confidence Barometer (CCB19), a two-yearly survey of more than 2,600 executives in 45 countries, found that 67 per cent of UK life sciences executives were on the sidelines about the impact of Brexit on investment and acquisition activity. Globally, however, the situation is less optimistic, with 51 per cent of executives surveyed saying Brexit will have a negative impact on investments and acquisitions outside the UK and the EU, as well as their ability to recruit and retain key talent.
    the report, the global life sciences industry is on track to make $200 billion in deals by 2018, but with only 49 percent saying the industry's economy is improving, the outlook looks even more erring.
    Matt Bartel, leader of EY UK Life Sciences TAS, commented: "It is not surprising that British retirees are more confident about Brexit than their global counterparts.
    "Clearly, people in the life sciences industry have done their homework and are ahead of many others to make sure they are ready for the Brexit storm and can continue to focus on driving growth through mergers and acquisitions." He continued, "We have seen companies prepare to move part of their supply chains to the European Economic Area and store medicines in response to any possible direct disruption." This
    is in stark contrast to the potential regulatory turmoil after Brexit at the European Medicines Agency. Moving from London to Amsterdam will force the agency to scale back its activities by leaving 30 per cent of its staff on January 1. (This net special draft)
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.